Cargando…

Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial

PURPOSE: The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors’ self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Singleton, Anna C., Raeside, Rebecca, Partridge, Stephanie R., Hyun, Karice K., Tat-Ko, Justin, Sum, Stephanie Che Mun, Hayes, Molly, Chow, Clara K., Thiagalingam, Aravinda, Maka, Katherine, Sherman, Kerry A., Elder, Elisabeth, Redfern, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034445/
https://www.ncbi.nlm.nih.gov/pubmed/35460441
http://dx.doi.org/10.1007/s11764-022-01209-9
_version_ 1784693113430736896
author Singleton, Anna C.
Raeside, Rebecca
Partridge, Stephanie R.
Hyun, Karice K.
Tat-Ko, Justin
Sum, Stephanie Che Mun
Hayes, Molly
Chow, Clara K.
Thiagalingam, Aravinda
Maka, Katherine
Sherman, Kerry A.
Elder, Elisabeth
Redfern, Julie
author_facet Singleton, Anna C.
Raeside, Rebecca
Partridge, Stephanie R.
Hyun, Karice K.
Tat-Ko, Justin
Sum, Stephanie Che Mun
Hayes, Molly
Chow, Clara K.
Thiagalingam, Aravinda
Maka, Katherine
Sherman, Kerry A.
Elder, Elisabeth
Redfern, Julie
author_sort Singleton, Anna C.
collection PubMed
description PURPOSE: The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors’ self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy medication adherence, physical activity, BMI) health. METHODS: Single-blind randomised controlled trial (1:1) comparing EMPOWER-SMS to usual care at 6-months (intention-to-treat). Setting: public Breast Cancer Institute (Sydney, Australia). Eligibility criteria: adult (> 18 years) females, < 18-months post-active breast cancer treatment (stage I-III), owned a mobile phone, written informed consent. Primary outcome: Self-Efficacy for Managing Chronic Disease Scale at 6 months. Process data: message delivery analytics, cost, and post-intervention survey. RESULTS: Participants (N = 160; mean age ± SD 55.1 ± 11.1 years) were recruited 29th-March-2019 to 7th-May-2020 and randomised (n = 80 EMPOWER-SMS: n = 80 control). Baseline mean self-efficacy was high (I: 7.1 [95%CI 6.6, 7.5], C: 7.4 [7, 7.8]). Six-month follow-up: no significant differences between groups for self-efficacy (I: 7.6 [7.3, 7.9], C: 7.6 [7.3, 7.9], adjusted mean difference 0 (95%CI 0.4, 0.4), QOL, mental health, physical activity, or BMI. Significantly less EMPOWER-SMS participants missed ≥ 1 endocrine therapy medication doses compared to control (I: 3/42[7.1%], C: 8/47[17.0%], Adjusted RR 0.13 [95%CI 0.02, 0.91]). Text messages were delivered successfully (7925/8061, 98.3%), costing $13.62USD/participant. Participants strongly/agreed EMPOWER-SMS was easy-to-understand (64/64; 100%), useful (58/64; 90.6%), motivating for lifestyle change (43/64; 67.2%) and medication adherence (22/46; 47.8%). CONCLUSION: EMPOWER-SMS was feasible, inexpensive, acceptable for delivering health information to breast cancer survivors between medical appointments, with minor improvements in medication adherence. IMPLICATIONS FOR CANCER SURVIVORS: Text messages offer a feasible strategy for continuity-of-care between medical appointments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-022-01209-9.
format Online
Article
Text
id pubmed-9034445
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-90344452022-04-25 Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial Singleton, Anna C. Raeside, Rebecca Partridge, Stephanie R. Hyun, Karice K. Tat-Ko, Justin Sum, Stephanie Che Mun Hayes, Molly Chow, Clara K. Thiagalingam, Aravinda Maka, Katherine Sherman, Kerry A. Elder, Elisabeth Redfern, Julie J Cancer Surviv Original Research PURPOSE: The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors’ self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy medication adherence, physical activity, BMI) health. METHODS: Single-blind randomised controlled trial (1:1) comparing EMPOWER-SMS to usual care at 6-months (intention-to-treat). Setting: public Breast Cancer Institute (Sydney, Australia). Eligibility criteria: adult (> 18 years) females, < 18-months post-active breast cancer treatment (stage I-III), owned a mobile phone, written informed consent. Primary outcome: Self-Efficacy for Managing Chronic Disease Scale at 6 months. Process data: message delivery analytics, cost, and post-intervention survey. RESULTS: Participants (N = 160; mean age ± SD 55.1 ± 11.1 years) were recruited 29th-March-2019 to 7th-May-2020 and randomised (n = 80 EMPOWER-SMS: n = 80 control). Baseline mean self-efficacy was high (I: 7.1 [95%CI 6.6, 7.5], C: 7.4 [7, 7.8]). Six-month follow-up: no significant differences between groups for self-efficacy (I: 7.6 [7.3, 7.9], C: 7.6 [7.3, 7.9], adjusted mean difference 0 (95%CI 0.4, 0.4), QOL, mental health, physical activity, or BMI. Significantly less EMPOWER-SMS participants missed ≥ 1 endocrine therapy medication doses compared to control (I: 3/42[7.1%], C: 8/47[17.0%], Adjusted RR 0.13 [95%CI 0.02, 0.91]). Text messages were delivered successfully (7925/8061, 98.3%), costing $13.62USD/participant. Participants strongly/agreed EMPOWER-SMS was easy-to-understand (64/64; 100%), useful (58/64; 90.6%), motivating for lifestyle change (43/64; 67.2%) and medication adherence (22/46; 47.8%). CONCLUSION: EMPOWER-SMS was feasible, inexpensive, acceptable for delivering health information to breast cancer survivors between medical appointments, with minor improvements in medication adherence. IMPLICATIONS FOR CANCER SURVIVORS: Text messages offer a feasible strategy for continuity-of-care between medical appointments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-022-01209-9. Springer US 2022-04-23 2023 /pmc/articles/PMC9034445/ /pubmed/35460441 http://dx.doi.org/10.1007/s11764-022-01209-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Singleton, Anna C.
Raeside, Rebecca
Partridge, Stephanie R.
Hyun, Karice K.
Tat-Ko, Justin
Sum, Stephanie Che Mun
Hayes, Molly
Chow, Clara K.
Thiagalingam, Aravinda
Maka, Katherine
Sherman, Kerry A.
Elder, Elisabeth
Redfern, Julie
Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial
title Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial
title_full Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial
title_fullStr Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial
title_full_unstemmed Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial
title_short Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial
title_sort supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the empower-sms randomised clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034445/
https://www.ncbi.nlm.nih.gov/pubmed/35460441
http://dx.doi.org/10.1007/s11764-022-01209-9
work_keys_str_mv AT singletonannac supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT raesiderebecca supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT partridgestephanier supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT hyunkaricek supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT tatkojustin supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT sumstephaniechemun supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT hayesmolly supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT chowclarak supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT thiagalingamaravinda supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT makakatherine supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT shermankerrya supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT elderelisabeth supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial
AT redfernjulie supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial